PROGRAM SCHEDULED for May 12-14, 2026 | Virtual
Bryant Aaron
Chief Compliance Officer, Elevance Health, Inc.
Rosa M. Alves
Asst. Dean, Global Compliance, Seton Hall Law School
Cindy Cetani
Chief Integrity & Compliance Officer, Indivior Inc.
Jill Dailey
Chief Compliance Officer, Incyte
Christian Dingler
Executive Director Risk Management and Program Effectiveness, Global Compliance,
Insmed
Signe Elbaek
Chief Compliance Officer, Mölnlycke Health Care AB (Denmark)
Jacob T. Elberg
Professor of Law and Faculty Director, Center for Health & Pharmaceutical Law, Seton Hall Law School
Matthew Galvin
Co-Founder, Gentic Global Advisors PLLC
Gary Giampetruzzi
Partner, Litigation Department, Paul Hastings, LLP
Joshua L. Haber
Chief of the Criminal Division, U.S. Attorney’s Office for the District of New Jersey
Daniel Kahn
Partner, Davis Polk
Keith M. McGahan
Board of Directors, WiNK Therapeutics, Chief Legal Officer, ALG Senior, and General Counsel & Chief Compliance Officer, Nouveau Biosciences
Jennifer McGee
Sr. VP & Global Chief Compliance Officer, Otsuka Pharmaceutical
Jonathan Mehta
Assistant General Counsel, Litigation & Investigations – Asia Pacific & North America,
Johnson & Johnson
Piergiorgio Pepe
President, Quantum Ethics
Joseph Philipose
SVP, Chief Ethics & Compliance Officer, Emergent Biosolutions, Inc.
Lawrence Platkin
VP & Head, U.S. Office of Compliance (Retired), Bayer U.S. LLC
Erica Powers
Vice President, Chief Compliance Officer, Sage Therapeutics
Jaimee Reid
Head of Compliance and Privacy Officer, Intercept Pharmaceuticals
Jonathan Stevens
Partner, Litigation Department, Paul Hastings, LLP
Joseph Zimmerman
Sr. VP, Chief Compliance Officer, SpringWorks Therapeutics, Inc.